Dasman Diabetes Institute

Running trials

• Recruiting

  Tirzepatide Titration to Reduce Side Effects in Individuals With Obesity

  NCT07574723· Source

• Recruiting

  Early Detection of Type 1 Diabetes in First Degree Relatives of Type 1 Diabetes Patients (DETECT T1D GULF)

  NCT07038473· Source

• Not yet recruiting

  Can the Addition of Pioglitazone to SGLT2 Inhibitor in Type 1 Diabetic Patients Amplify the Decrease in HbA1c and Prevent the Increase in Plasma Ketone Concentration?

  NCT06922656· Phase 4· Source

• Recruiting

  LEAN Mass Preservation With Resistance Exercise and Protein During Semaglutide/Tirzepatide Therapy

  NCT06885736· Source

• Recruiting

  Tirzepatide Use in People With Obesity and Type 1 Diabetes

  NCT07096908· Phase 4· Source

• Recruiting

  Structured Education Program and Glycemic Control in Adolescents With Type 1 Diabetes

  NCT06984133· Source

• Enrolling by invitation

  Compare Multiple Daily Injections With Carbohydrate Counting or With Simplified Qualitative Meal-Size Estimation in Type 1 Diabetes

  NCT07037810· Source

• Recruiting

  Kuwait Adult Diabetes Epidemiological Multidisciplinary (KADEM) Program

  NCT06115876· Source

• Enrolling by invitation

  Dapagliflozin Effect on Glucose Variability in Patients Post Bariatric Surgery

  NCT07515391· Phase 2· Source

• Active, not recruiting

  Dapagliflozin Plus Pioglitazone in T1DM

  NCT03878459· Phase 4· Source

Recruiting at the same time

How many trials recruit for the same indication here at once. A count, not a rating.

• Type 1 diabetes6 recruiting
• Obesity3 recruiting
• Type 2 diabetes2 recruiting
• Fatty liver disease (MASLD/MASH)1 recruiting

Researchers

No researcher is linked here yet.

Closed trials

• Completed

  Obesity Treatment to Improve Diabetes

  NCT05390307· Source

Trial sites

• Dasman Diabetes Institute10 trials
• Dasman Diabetes Institute - Site Number: 081 trial

Conditions

Diseases this institution publishes on or runs trials for.

• Type 1 diabetes20 works · 8 trials